APA (7th ed.) Citation

Robe, P. A., Martin, D. H., Nguyen-Khac, M. T., Artesi, M., Deprez, M., Albert, A., . . . Bours, V. (2009). Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults. BMC cancer, 9(1), 372. https://doi.org/10.1186/1471-2407-9-372

Chicago Style (17th ed.) Citation

Robe, Pierre A., et al. "Early Termination of ISRCTN45828668, a Phase 1/2 Prospective, Randomized Study of Sulfasalazine for the Treatment of Progressing Malignant Gliomas in Adults." BMC Cancer 9, no. 1 (2009): 372. https://doi.org/10.1186/1471-2407-9-372.

MLA (9th ed.) Citation

Robe, Pierre A., et al. "Early Termination of ISRCTN45828668, a Phase 1/2 Prospective, Randomized Study of Sulfasalazine for the Treatment of Progressing Malignant Gliomas in Adults." BMC Cancer, vol. 9, no. 1, 2009, p. 372, https://doi.org/10.1186/1471-2407-9-372.